USANA Health Sciences Inc (USNA) Stock Price

USNAStock

$15.54−26.25%52W

Market Cap$287.13M

P/E26.68x

PEG Ratio0.72

Div yield—

Beta0.66

USNA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-25.95%

Price vs S&P 500 (4W)8.57%

PEG Ratio0.72

VGM Score48.62

P/E Ratio (Annual)26.68x

P/CF (Annual)12.85x

Book Value / Share (Quarterly)$29.45

P/TBV (Annual)0.87x

Revenue Growth (3Y)-2.51%

Cash Flow / Share (Quarterly)$0.16

Price vs S&P 500 (YTD)-32.76%

Gross Margin (TTM)77.55%

Net Profit Margin (TTM)0.96%

EPS (TTM)$0.48

10-Day Avg Trading Volume0.19M

EPS Excl Extra (TTM)$0.48

Revenue Growth (5Y)-4.00%

EPS (Annual)$0.58

ROI (Annual)1.97%

Gross Margin (Annual)78.29%

Net Profit Margin (5Y Avg)5.96%

Cash / Share (Quarterly)$8.82

P/E Basic Excl Extra (TTM)32.36x

Revenue Growth QoQ (YoY)0.27%

EPS Growth (5Y)-37.04%

P/E Normalized (Annual)26.68x

ROA (Last FY)1.45%

Revenue Growth TTM (YoY)5.67%

EBITD / Share (TTM)$3.71

ROE (5Y Avg)13.64%

Operating Margin (TTM)3.85%

Cash Flow / Share (Annual)$0.47

P/B Ratio0.53x

P/B Ratio (Quarterly)0.59x

Net Income / Employee (Annual)$6,900

EV / Revenue (TTM)0.15x

Net Interest Coverage (TTM)103.00x

ROA (TTM)1.21%

EPS Growth QoQ (YoY)-17.13%

EV / EBITDA (TTM)2.03x

EPS Incl Extra (Annual)$0.58

Current Ratio (Annual)2.24x

Quick Ratio (Quarterly)1.47x

3-Month Avg Trading Volume0.17M

52-Week Price Return-26.25%

EV / Free Cash Flow (Annual)16.23x

P/E Incl Extra (TTM)32.36x

Revenue / Employee (TTM)$589,800

Tangible BV / Share (Quarterly)$22.47

P/S Ratio (Annual)0.31x

Asset Turnover (Annual)1.25x

52-Week High$23.59

Operating Margin (5Y Avg)9.41%

EPS Excl Extra (Annual)$0.58

CapEx CAGR (5Y)-1.75%

Tangible BV CAGR (5Y)-0.54%

26-Week Price Return-16.05%

Quick Ratio (Annual)1.35x

13-Week Price Return-28.78%

Total Debt / Equity (Annual)0.03x

Current Ratio (Quarterly)2.51x

Enterprise Value$138.37M

Revenue / Share Growth (5Y)-1.33%

Asset Turnover (TTM)1.26x

Book Value / Share Growth (5Y)6.75%

Revenue / Employee (Annual)$589,300

Inventory Turnover (Annual)2.46x

Pretax Margin (Annual)4.49%

Cash / Share (Annual)$8.66

3-Month Return Std Dev78.26%

Gross Margin (5Y Avg)80.49%

Net Income / Employee (TTM)$5,700

EBITDA CAGR (5Y)-18.12%

EBITDA Interim CAGR (5Y)-14.11%

ROE (Last FY)2.02%

Net Interest Coverage (Annual)50.22x

EPS Basic Excl Extra (Annual)$0.58

P/FCF (TTM)20.07x

Receivables Turnover (TTM)248.40x

EV / Free Cash Flow (TTM)46.73x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$0.48

Receivables Turnover (Annual)326.57x

ROI (TTM)1.64%

P/S Ratio (TTM)0.31x

Pretax Margin (5Y Avg)9.96%

Revenue / Share (Annual)$49.81

Tangible BV / Share (Annual)$21.88

Forward P/E20.45x

Free OCF CAGR (5Y)-43.29%

Price vs S&P 500 (52W)-41.78%

P/E Ratio (TTM)32.36x

EPS Growth TTM (YoY)-73.96%

Year-to-Date Return-20.84%

5-Day Price Return3.95%

EPS Normalized (Annual)$0.58

ROA (5Y Avg)9.79%

Net Profit Margin (Annual)1.16%

Month-to-Date Return7.39%

Cash Flow / Share (TTM)$3.77

EBITD / Share (Annual)$3.77

EPS Growth (3Y)-45.59%

Operating Margin (Annual)4.05%

LT Debt / Equity (Annual)0.09x

P/CF (TTM)17.27x

ROI (5Y Avg)13.56%

P/E Excl Extra (TTM)32.36x

LT Debt / Equity (Quarterly)0.27x

EPS Basic Excl Extra (TTM)$0.48

P/TBV (Quarterly)0.78x

P/B Ratio (Annual)0.65x

Inventory Turnover (TTM)2.45x

Pretax Margin (TTM)4.35%

Book Value / Share (Annual)$29.16

Price vs S&P 500 (13W)-31.47%

Net Margin Growth (5Y)-36.22%

Beta0.66x

P/FCF (Annual)33.68x

Revenue / Share (TTM)$50.29

ROE (TTM)1.66%

52-Week Low$12.57

vGradeB

gGradeD

mGradeC

vgmGradeC

USNA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.43	-$0.07	-116.28%(-$0.50)
Q1 2026	May 5, 2026	$0.44	$0.61	+38.64%(+$0.17)
Q4 2025	Feb 17, 2026	$0.41	$0.60	+46.34%(+$0.19)
Q3 2025	Oct 22, 2025	-$0.15	-$0.15	+0.00%(+$0.00)
Q2 2025	Jul 22, 2025	$0.54	$0.74	+37.04%(+$0.20)

USNA Analyst Recommendations

Mar 2025

Apr 2025

May 2025

Jun 2025

2.17

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About USANA Health Sciences Inc

USANA Health Sciences Inc develops and manufactures science-based nutritional, personal care, and skincare products focused on long-term health and wellness. The company operates through two segments: direct selling, which generates the majority of revenue across multiple geographic markets, and Hiya, a direct-to-consumer children's health brand in the U.S. These dual channels allow USANA to reach both adult and pediatric wellness markets globally.